AVAH

Aveanna Healthcare Holdings Inc. (AVAH) | Rumor.io

Aveanna Healthcare Holdings

AVAH

Attention (50-day avg)0%

Attention rank (50-day avg)#1,580

Bullish sentiment (50-day avg)94%

Price to earnings ratio9.85

Market capitalization2.8B

Earnings per share1.26

Dividend yield (TTM)—

Revenue (annual)2.4B

Net income (annual)225M

Social

What share of all stock conversation is about AVAH?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

Aug 21

Aveanna Healthcare Holdings Inc. ($AVAH) priced a 15 million-share secondary offering at $11.75 per share.
The offering provides existing owners with liquidity without issuing new shares, valued at $176 million.
$AVAH's stock price decreased by 6.2% and 6.7% respectively prior to and following the offering announcement.

Generated by AI

Sentiment

Of the messages about AVAH that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100% new	75% -21.77	98.48% +7.04
Bearish	0%	0% -100	25% +21.77	1.52% -7.04

Aug 7

$AVAH is superundervalued with a strong Q2 earnings report, including revenue up 16.75% YoY and adjusted EPS up 1700% YoY.
Institutional ownership is high at 195.1M, representing 87.61% of the shares, and short interest is low at 4.49% of float.
$AVAH has broken out above key support, with buyers stepping in and the stock resetting above its prior ATH, indicating potential for further gains.

Generated by AI

Topics

Of the messages about AVAH that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	0%	0%	58.97%
Technical Analysis	—	0%	76.19%	19.05%
Analysts	—	100%	23.81%	13.19%
Earnings	—	0%	0%	8.79%
Controversies	—	0%	0%	0%
Macro	—	0%	0%	0%

Earnings· Apr 24

Aveanna Healthcare Holdings Inc. (AVAH) has announced its first quarter 2023 earnings release date and conference call.
The conference call details are expected to be released soon.
The exact date of the conference call is not specified in the announcement.

Analysts· May 24

Aveanna Healthcare Holdings Inc. (AVAH) has received analyst coverage from multiple firms, with ratings ranging from Buy to Neutral.
Analysts have set price targets for AVAH, with estimates ranging from $13.5 to $17.
Firms such as Jefferies, RBC Capital, and Deutsche Bank have initiated coverage on AVAH with Buy or Outperform ratings, while JP Morgan has a Neutral rating.

Announcements· Mar 13

Aveanna Healthcare Holdings Inc. has reported quarterly profit and expects organic volume growth and enhanced profitability into 2025.
The company has exceeded expectations for its Q4 2024 financial results, with revenue of $519.9M and adjusted EPS of 5c, compared to consensus estimates of $499.61M and 0c.
Aveanna Healthcare Holdings has filed Form S-8 registrations to register additional shares of its common stock under the 2021 Stock Incentive Plan and the 2021 Employee Stock Purchase Plan, increasing the number of shares available for issuance.

Generated by AI

Community

Of the messages about AVAH, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	66.67%	2.6%	11.14%
Newcomers	100%	33.33%	97.4%	88.86%

Aug 13

Aveanna Healthcare's Q2 earnings beat expectations, with revenue of $670.5M and adjusted EPS of 22 cents, a significant improvement over the 17-cent estimate.
The company's share price surged ~16.2% to a five-year high of $10.68, with market cap reaching $2.5B and volume of 10.1M.
Aveanna Healthcare raised its FY26 guidance to $2.68B revenue and $365M adjusted EBITDA, driven by strong Q2 results and concrete profitability and cash flow progress.

Generated by AI

News

Analysts Conflicted on These Healthcare Names: Ocugen (OCGN), Aveanna Healthcare Holdings (AVAH) and Universal Health (UHS)

Detailed price information for Universal Health Services (UHS-N) from The Globe and Mail including charting and trades.

22h agoThe Globe and Mail

Raymond James initiates Aveanna Healthcare stock coverage with Strong Buy

1d agoInvesting.com

Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

5d agoYahoo Finance

Jim Cramer Compares Aveanna Healthcare (AVAH) With Hinge Health (HNGE)

A caller asked for Jim Cramer’s long-term thoughts on Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the lightning round of the September 14 episode of Mad Money. He replied: They have a good model. They remind me of Hinge, not exactly, but in just this kind of discreet good model will make money. And I think […]

11d agoYahoo Finance

Here's Why Aveanna Healthcare (AVAH) is a Great Momentum Stock to Buy

Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

12d agoYahoo Finance

Aveanna Healthcare at Deutsche Bank 2026 Healthcare Summit: growth pivot

13d agoInvesting.com

Also Discussed

Investors talking about AVAH also mention

#	Name	Attention
1	Invesco Dorsey Wright Basic Materials Momentum ETFPYZ	0%0
2	Xtrackers US Green Infrastructure Select Equity ETFUPGR	0%0
3	ArriVent BioPharma, Inc.AVBP	0%new
4	IceCure Medical Ltd.ICCM	0%0
5	Hub Group Inc.HUBG	0%new
6	Entegris Inc.ENTG	0%0
7	Silicom Ltd.SILC	0%0
8	Expion360 Inc.XPON	0%0
9	Goldman Sachs Nasdaq-100 Premium Income ETFGPIQ	0.34%-0.21
10	PIMCO Active Bond Exchange-Traded FundBOND	0%-0.72

Aveanna Healthcare Holdings Inc.

Healthcare
Medical Care Facilities

Aveanna Healthcare Holdings Inc. is a diversified home care company that provides pediatric and adult healthcare services across the United States. Aveanna Healthcare Holdings Inc. focuses on care delivered in the home and in community-based settings, serving medically complex and chronically ill patients through private duty nursing, home health, hospice, therapy, rehabilitation, and related support services. The company also offers enteral nutrition and other medical products for patients with specialized care needs. Its services are organized across Private Duty Services, Home Health & Hospice, and Medical Solutions, allowing it to address a broad range of clinical and non-clinical needs for newborns, children, adults, and seniors. Headquartered in Atlanta, Georgia, Aveanna Healthcare Holdings Inc. plays a significant role in the U.S. healthcare services market by helping patients receive coordinated care outside traditional institutional settings.

Website

Location

400 Interstate North Parkway SE

Atlanta, GA, 30339

United States

Social

What share of all stock conversation is about AVAH?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

Aug 21

Aveanna Healthcare Holdings Inc. ($AVAH) priced a 15 million-share secondary offering at $11.75 per share.
The offering provides existing owners with liquidity without issuing new shares, valued at $176 million.
$AVAH's stock price decreased by 6.2% and 6.7% respectively prior to and following the offering announcement.

Generated by AI

Sentiment

Of the messages about AVAH that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100% new	75% -21.77	98.48% +7.04
Bearish	0%	0% -100	25% +21.77	1.52% -7.04

Aug 7

$AVAH is superundervalued with a strong Q2 earnings report, including revenue up 16.75% YoY and adjusted EPS up 1700% YoY.
Institutional ownership is high at 195.1M, representing 87.61% of the shares, and short interest is low at 4.49% of float.
$AVAH has broken out above key support, with buyers stepping in and the stock resetting above its prior ATH, indicating potential for further gains.

Generated by AI

Topics

Of the messages about AVAH that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	0%	0%	58.97%
Technical Analysis	—	0%	76.19%	19.05%
Analysts	—	100%	23.81%	13.19%
Earnings	—	0%	0%	8.79%
Controversies	—	0%	0%	0%
Macro	—	0%	0%	0%

Earnings· Apr 24

Aveanna Healthcare Holdings Inc. (AVAH) has announced its first quarter 2023 earnings release date and conference call.
The conference call details are expected to be released soon.
The exact date of the conference call is not specified in the announcement.

Analysts· May 24

Aveanna Healthcare Holdings Inc. (AVAH) has received analyst coverage from multiple firms, with ratings ranging from Buy to Neutral.
Analysts have set price targets for AVAH, with estimates ranging from $13.5 to $17.
Firms such as Jefferies, RBC Capital, and Deutsche Bank have initiated coverage on AVAH with Buy or Outperform ratings, while JP Morgan has a Neutral rating.

Announcements· Mar 13

Aveanna Healthcare Holdings Inc. has reported quarterly profit and expects organic volume growth and enhanced profitability into 2025.
The company has exceeded expectations for its Q4 2024 financial results, with revenue of $519.9M and adjusted EPS of 5c, compared to consensus estimates of $499.61M and 0c.
Aveanna Healthcare Holdings has filed Form S-8 registrations to register additional shares of its common stock under the 2021 Stock Incentive Plan and the 2021 Employee Stock Purchase Plan, increasing the number of shares available for issuance.

Generated by AI

Community

Of the messages about AVAH, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	66.67%	2.6%	11.14%
Newcomers	100%	33.33%	97.4%	88.86%

Aug 13

Aveanna Healthcare's Q2 earnings beat expectations, with revenue of $670.5M and adjusted EPS of 22 cents, a significant improvement over the 17-cent estimate.
The company's share price surged ~16.2% to a five-year high of $10.68, with market cap reaching $2.5B and volume of 10.1M.
Aveanna Healthcare raised its FY26 guidance to $2.68B revenue and $365M adjusted EBITDA, driven by strong Q2 results and concrete profitability and cash flow progress.

Generated by AI

Aveanna Healthcare Holdings

Social

Aug 21

Aug 7

Earnings· Apr 24

Analysts· May 24

Announcements· Mar 13

Aug 13

Analysts Conflicted on These Healthcare Names: Ocugen (OCGN), Aveanna Healthcare Holdings (AVAH) and Universal Health (UHS)

Raymond James initiates Aveanna Healthcare stock coverage with Strong Buy

Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?

Jim Cramer Compares Aveanna Healthcare (AVAH) With Hinge Health (HNGE)

Here's Why Aveanna Healthcare (AVAH) is a Great Momentum Stock to Buy

Aveanna Healthcare at Deutsche Bank 2026 Healthcare Summit: growth pivot

Also Discussed

Aveanna Healthcare Holdings Inc.

Company Information

Location

Analysts Conflicted on These Healthcare Names: Ocugen (OCGN), Aveanna Healthcare Holdings (AVAH) and Universal Health (UHS)

Raymond James initiates Aveanna Healthcare stock coverage with Strong Buy

Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?

Jim Cramer Compares Aveanna Healthcare (AVAH) With Hinge Health (HNGE)

Here's Why Aveanna Healthcare (AVAH) is a Great Momentum Stock to Buy

Aveanna Healthcare at Deutsche Bank 2026 Healthcare Summit: growth pivot

Also Discussed

Social

Aug 21

Aug 7

Earnings· Apr 24

Analysts· May 24

Announcements· Mar 13

Aug 13